{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T17:35:46Z","timestamp":1778952946395,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003653","name":"Korea National Institute of Health","doi-asserted-by":"publisher","award":["4800-4845-300"],"award-info":[{"award-number":["4800-4845-300"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003653","name":"Korea National Institute of Health","doi-asserted-by":"publisher","award":["4800-4859-300"],"award-info":[{"award-number":["4800-4859-300"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003653","name":"Korea National Institute of Health","doi-asserted-by":"publisher","award":["KNIH 2017-NI47001-00"],"award-info":[{"award-number":["KNIH 2017-NI47001-00"]}],"id":[{"id":"10.13039\/501100003653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.vaccine.2021.01.039","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T05:41:09Z","timestamp":1614318069000},"page":"1870-1876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cross-neutralization between vaccine and circulating wild-type mumps viruses in Korea"],"prefix":"10.1016","volume":"39","author":[{"given":"Hyeran","family":"Won","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ah-Ra","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8145-5039","authenticated-orcid":false,"given":"Jung-Sik","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyung Tae","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hae Ji","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Soon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June-Woo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.01.039_b0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/rmv.1819","article-title":"Genomic diversity of mumps virus and global distribution of the 12 genotypes","volume":"25","author":"Jin","year":"2015","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.vaccine.2021.01.039_b0010","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/path.4445","article-title":"Molecular biology, pathogenesis, and pathology of mumps virus","volume":"235","author":"Rubin","year":"2015","journal-title":"J Pathol"},{"key":"10.1016\/j.vaccine.2021.01.039_b0015","doi-asserted-by":"crossref","unstructured":"WHO. Mumps virus nomenclature update: 2012. Week Epidemiol Rec (WER) 2012; 87:217-24. https:\/\/doi.org\/10.1002\/path.4445.","DOI":"10.1002\/path.4445"},{"key":"10.1016\/j.vaccine.2021.01.039_b0020","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1002\/jmv.24515","article-title":"Genetic characteristics of mumps viruses isolated in Korea from 2007 to 2012","volume":"88","author":"Kim","year":"2016","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2021.01.039_b0025","unstructured":"KDCA. Vaccination Assistant. https:\/\/nip.cdc.go.kr\/irgd\/reference.do?MnLv1=7 (in Korean). Accessed 31 July, 2020."},{"key":"10.1016\/j.vaccine.2021.01.039_b0030","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1442-200X.2010.03244.x","article-title":"Reappraisal of MMR vaccines currently used in Korea","volume":"53","author":"Lee","year":"2011","journal-title":"Pediatr Int"},{"key":"10.1016\/j.vaccine.2021.01.039_b0035","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3345\/kjp.2012.55.12.455","article-title":"Current status of measles in the Republic of Korea: An overview of case-based and seroepidemiological surveillance scheme","volume":"55","author":"Choe","year":"2012","journal-title":"Korean J Pediatr"},{"key":"10.1016\/j.vaccine.2021.01.039_b0040","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijid.2017.02.011","article-title":"Increasing mumps incidence rates among children and adolescents in the Republic of Korea: Age-period-cohort analysis","volume":"57","author":"Choe","year":"2017","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.039_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3947\/ic.2015.47.1.1","article-title":"Resurgence of mumps in Korea","volume":"47","author":"Park","year":"2015","journal-title":"Infect Chemother"},{"key":"10.1016\/j.vaccine.2021.01.039_b0050","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1056\/NEJMoa0706589","article-title":"Recent resurgence of mumps in the United States","volume":"358","author":"Dayan","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.01.039_b0055","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.4161\/hv.29484","article-title":"Outbreak of mumps in a school setting, United Kingdom, 2013","volume":"10","author":"Aasheim","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2021.01.039_b0060","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1016\/j.vaccine.2014.06.069","article-title":"Mumps increase in Flanders, Belgium, 2012\u20132013: Results from temporary mandatory notification and a cohort study among university students","volume":"32","author":"Braeye","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.01.039_b0065","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1473-3099(18)30498-5","article-title":"A protracted mumps outbreak in Western Australia despite high vaccine coverage: A population-based surveillance study","volume":"19","author":"Westphal","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2021.01.039_b0070","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/cid\/cix718","article-title":"Mumps outbreak in a highly vaccinated university-affiliated setting before and after a measles-mumps-rubella vaccination campaign-Iowa, July 2015-May 2016","volume":"66","author":"Shah","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.01.039_b0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-1702(00)00254-9","article-title":"Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein","volume":"74","author":"Cusi","year":"2001","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2021.01.039_b0080","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.virol.2006.09.040","article-title":"Mapping antigenic diversity and strain specificity of mumps virus: A bioinformatics approach","volume":"359","author":"Kulkarni-Kale","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2021.01.039_b0085","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1017\/S0950268812001896","article-title":"Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies","volume":"141","author":"Santak","year":"2013","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2021.01.039_b0090","doi-asserted-by":"crossref","first-page":"13337","DOI":"10.1038\/s41598-018-31630-z","article-title":"Differences in antigenic sites and other functional regions between genotype A and G mumps virus surface proteins","volume":"8","author":"Gouma","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2021.01.039_b0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jviromet.2009.09.006","article-title":"Development of a focus reduction neutralization test (FRNT) for detection of mumps virus neutralizing antibodies","volume":"163","author":"Vaidya","year":"2010","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2021.01.039_b0100","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/1348-0421.12201","article-title":"Detection of measles, mumps, and rubella viruses by immuno-colorimetric assay and its application in focus reduction neutralization tests","volume":"58","author":"Vaidya","year":"2014","journal-title":"Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.01.039_b0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vaccine.2007.10.046","article-title":"Plaque reduction neutralization test for measles antibodies: description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination","volume":"26","author":"Cohen","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.01.039_b0110","unstructured":"KDCA. Infectious Disease Portal. http:\/\/www.cdc.go.kr\/npt\/biz\/npp\/ist\/bass\/bassSexdstnAgeStatsMain.do (in Korean). Accessed 1 January, 2021."},{"key":"10.1016\/j.vaccine.2021.01.039_b0115","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1016\/j.vaccine.2018.05.067","article-title":"Knowledge gaps persist and hinder progress in eliminating mumps","volume":"36","author":"Ramanathan","year":"2018","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2021.01.039_b0120","first-page":"e00151","article-title":"Mumps: an update on outbreaks, vaccine efficacy, and genomic diversity","volume":"3","author":"Lam","year":"2020","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2021.01.039_b0125","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","article-title":"Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: A 20-year follow-up","volume":"197","author":"Davidkin","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.01.039_b0130","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.vaccine.2017.12.075","article-title":"Measles, mumps, and rubella antibody patterns of persistence and rate of decline following the second dose of the MMR vaccine","volume":"36","author":"Seagle","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.01.039_b0135","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.vaccine.2019.02.030","article-title":"Differential durability of immune responses to measles and mumps following MMR vaccination","volume":"37","author":"Kennedy","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.01.039_b0140","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1016\/j.vaccine.2019.07.049","article-title":"Long-term immunogenicity of measles, mumps and rubella-containing vaccines in healthy young children: A 10-year follow-up","volume":"37","author":"Carryn","year":"2019","journal-title":"Vaccine"},{"issue":"ofu094","key":"10.1016\/j.vaccine.2021.01.039_b0145","article-title":"Mumps antibody response in young adults after a third dose of measles-mumps-rubella vaccine. Open Forum","volume":"1","author":"Fiebelkorn","year":"2014","journal-title":"Infect Dis"},{"issue":"ofx263","key":"10.1016\/j.vaccine.2021.01.039_b0150","article-title":"Mumps virus nucleoprotein and hemagglutinin-specific antibody response following a third dose of measles mumps rubella vaccine. Open Forum","volume":"4","author":"Latner","year":"2017","journal-title":"Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2021.01.039_b0155","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/cid\/ciy779","article-title":"Characteristics of large mumps outbreaks in the united states, July 2010\u2013December 2015","volume":"68","author":"Clemmons","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2021.01.039_b0160","unstructured":"CDC. 2018. CDC guidance for public health authorities on use of a 3rd dose of MMR vaccine during mumps outbreaks. https:\/\/www.cdc.gov\/mumps\/health-departments\/MMR3.html. Accessed 29 January, 2020."},{"issue":"eaao5945","key":"10.1016\/j.vaccine.2021.01.039_b0165","article-title":"Vaccine waning and mumps re-emergence in the United States","volume":"10","author":"Lewnard","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2021.01.039_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000611","article-title":"Combining genomics and epidemiology to track mumps virus transmission in the United States","volume":"18","author":"Wohl","year":"2020","journal-title":"PLoS Biol"},{"key":"10.1016\/j.vaccine.2021.01.039_b0175","doi-asserted-by":"crossref","DOI":"10.1017\/S0950268812001896","article-title":"Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies","volume":"141","author":"Santak","year":"2013","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2021.01.039_b0180","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1086\/590115","article-title":"Antibody induced by immunization with the Jeryl Lynn mumps vaccine strain effectively neutralizes a heterologous wild-type mumps virus associated with a large outbreak","volume":"198","author":"Rubin","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2021.01.039_b0185","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cmi.2018.11.016","article-title":"Sera from different age cohorts in Belgium show limited cross-neutralization between the mumps vaccine and outbreak strains","volume":"25","author":"Vermeire","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2021.01.039_b0190","doi-asserted-by":"crossref","first-page":"19071","DOI":"10.1073\/pnas.1905570116","article-title":"Decreased humoral immunity to mumps in young adults immunized with MMR vaccine in childhood","volume":"116","author":"Rasheed","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4166\u201371","key":"10.1016\/j.vaccine.2021.01.039_b0195","article-title":"Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection","volume":"34","author":"Gouma","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.01.039_b0200","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4103\/0971-5916.178587","article-title":"Cross-neutralization between three mumps viruses & mapping of haemagglutinin-neuraminidase (HN) epitopes","volume":"143","author":"Vaidya","year":"2016","journal-title":"Indian J Med Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21000554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21000554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:54:14Z","timestamp":1759402454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21000554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":40,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0264410X21000554"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.01.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-neutralization between vaccine and circulating wild-type mumps viruses in Korea","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.01.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}